| 1. |
Lamanna, C. and Hart, E. R. (1968) Relationship of lethal toxic dose to body weight of the mouse, Toxicol. Appl. Pharmacol.
13, 307–315.
|
| |
| 2. |
Anderson, J. H. and Lewis, G. E., Jr. (1981) Clinical evaluation of botulinum toxoids, in Biomedical Aspects of Botulism, (Lewis, G.E., ed.), Academic Press, New York, NY, pp. 233–246.
|
| |
| 3. |
Simpson, L. L. (1986) Molecular pharmacology botulinum toxin and tetanus toxin, Annu. Rev. Pharmacol. Toxicol.
26, 427–453.
|
| |
| 4. |
DasGupta, B. R. (1989) The structure of botulinum neurotoxins, in Botulinum Neurotoxin and Tetanus Toxin, (L.L. Simpson, L.L., ed.), Academic Press, New York, NY, pp. 53–67.
|
| |
| 5. |
Simpson. L. L. (1981) The Origin, Structure, and Pharmacological Activity of Botulinum Toxin. Pharmacol. Rev.
33, 155–188.
|
| |
| 6. |
Poulain, B., Weller, U., Binz, T., et al. (1993) Functional Roles of the Domains of Clostridial Neurotoxins: The Contribution
from Studies on Aplysia, in Botulinum and Tenanus Neurontoxins: Neurotransmission and Biomedical Aspects (DasGupta, B. R., ed.), Plenum Press, New York, NY, pp 34–360.
|
| |
| 7. |
Black, J. D. and Dolly, J. O. (1986) Interaction of 125I-labeled Botulinum Neurotoxin with Nerve Terminals. I. Ultrastructual Autoradiographic Localization and Quantification of
Distinct Membrane Acceptors for Types A and B on Motor Nerves. J. Cell Biol.
103, 521–534.
|
| |
| 8. |
Nishiki, T.-I., Kamata, Y., Nemoto, Y. et al. (1994) Identification of Protein Receptor for Clostridium botulinum Type B Neurotoxin in Rat Brain Synaptosomes. J. Biol. Chem.
269, 10,498–10,503.
|
| |
| 9. |
Shone, C. C., Hambleton, P., and Melling, J. (1985) Inactivation of Clostridium botulinum Type A Neurotoxin by Trypsin and Purification of Two Tryptic Fragments. Proteolytic Cleavage Near the COOH-terminus of the
Heavy Subunit Destroys Toxin-Binding Activity. Eur. J. Biochem.
151, 75–82.
|
| |
| 10. |
Schiavo, G., Rossetto, O., Catsicas, S., et al. (1993) Identification of the Nerve Terminal Targets of Botulinum Neurotoxin
Serotypes A, D and E. E. J. Biol. Chem.
268, 23,784–23,787.
|
| |
| 11. |
Black, J. D. and Dolly, J. O. (1986) Interaction of 125I-labeled Botulinum Neurotoxin with Nerve Terminals. II. Autoradiographic Evidence for Its Uptake into Motor Nerves by Acceptor-mediated
Endocytosis. J. Cell Biol.
103, 535–544.
|
| |
| 12. |
Shone, C. C., Hambleton, P., and Melling, J. (1987) A 50-kDa Fragment from the NH2-terminus of the Heavy Subunit of Clostridium botulinum Type A Neurotoxin Forms Channels in Lipid Vesicles. Eur. J. Biochem.
167, 175–180.
|
| |
| 13. |
Blaustein, R. O., Germann, W. J., Finkelstein, A., and Dasgupta, B. R. (1987) The N-terminal Half of the Heacy Chain of Botulinum
Type A Neurotoxin Forms Channels in Planar Phospholipid Bilayers. FEBS Letters
226, 115–120.
|
| |
| 14. |
Montal, M. S., Blewitt, R. Tomich, J. M., and Montal, M. (1992) Identification of an Ion Channel-forming Motif in the Primary
Structure of Tetanus and Botulinum Neurotoxins. FEBS Letters
313, 12–18.
|
| |
| 15. |
Smith, L. A., Jensen M. J., Montgomery, V. A., Brown, D. R., Ahmed, S. A., and Smith, T. J. (2004) Roads from Vaccines to
Therapies. Mov. Disorders
19 Suppl. 8., S48–S52.
|
| |
| 16. |
Potter, K. J., Bevins, M. A., Vassilieva, E. V., et al. (1998) Production and Purification of the Heavy-Chain Fragment C of
Botulinum Neurotoxin, Serotype B, Expressed in the Methylotrophic Yeast Pichia pastoris. Prot. Exp. Purif.
13, 357–365.
|
| |
| 17. |
Potter, K. J., Zhang, W., Smith, L. A., and Meagher, M. M. (2000) Production and Purification of the Heavy Chain Fragment
C of Botulinum Neurotoxin, Serotype A, Expressed in the Methylotrophic Yeast Pichia pastoris. Prot. Exp. Purif.
19, 393–402.
|
| |
| 18. |
Fairweather, N. F., Lyness, V. A., and Maskell, D. J. (1987) Immunization of Mice Against Tetanus Toxin with Fragments of
Tetanus Toxin Synthesized in Escherichia coli. Infect. Immun.
55, 2541–2545.
|
| |
| 19. |
Makoff, A. J., Ballantine, S. P., Smallwood, A. E., and Fairweather, N. F. (1989) Expression of Tetanus Toxin Fragment C in
E. coli: Its Purification and Potenial Use as a Vaccine. Biotechnology
7, 1043–1046.
|
| |
| 20. |
Clayton, M. A., Clayton, J. M., Brown, D. R., and Middlebrook, J. L. (1995) Protective Vaccination with a Recombinant Fragment
of Clostridium botulinum Neurotoxin Serotype A Expressed from a Synthetic Gene in Escherichia coli. Infect. Immun.
63, 2738–2742.
|
| |
| 21. |
Byrne, M. P., Smith, T. J., Montgomery, V. A., and Smith, L. A. (1998) Purification potency, and efficacy of the botilinum
neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate. Infect. Immun.
66, 4817–4822.
|
| |
| 22. |
Byrne, M. P., Titball, R. W., Holley, J., and Smith, L.A. (2000) Fermentation, Purification, and efficacy of a recombinant
vaccine candidate against botulinum neurotoxin type F from Pichia pastoris. Protein Expr. Purif.
18, 327–337.
|
| |
| 23. |
Smith, L. A. and Byrne, M. P. (2002) Vaccines for preventing botulism, in Scientific and therapeutic aspects of botulinum toxin, (Brin M. F., Jankovic, J., Hallet, M., eds.), Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 427–440.
|
| |
| 24. |
Smith, L. A. (1998) Development of Recombinant Vaccines for Botulinum Neurotoxin. Toxicon. 36, 1539–1548.
|
| |
| 25. |
Zhang, W., Inan, M., and Meagher, M. M. (2000) Fermentation strategies for recombinant protein expression in methylotrophic
yeast Pichia pastoris. Biotechnol. Bioprocess. Eng.
5, 275–287.
|
| |
| 26. |
Zhang, W., Bevins, M. A., Plantz, B. A., Smith, L. A., and Meagher, M. M. (2000). Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin,
serotype A. Biotechnol. Bioeng.
70, 1–8.
|
| |
| 27. |
Scope, R. K. (ed.) (1994) Protein Purification — Principles and Practice (Third Edition). Springer-Verlag, New York, NY.
|
| |
| 28. |
Sinha, J., Plantz, B. A., Inan, M., and Meagher, M. M. (2005) Causes of Proteolytic Degradation of Secreted recombinant Proteins
Produced in Methyotrophic Yeast Pichia pastoris: case Study with Recombinatn Ovine Interferon. Biotechnol. Bioeng.
89, 102–112.
|
| |
| 29. |
Bollag, D. M., Rozycki, M. D., and Edelstein, S. J. (1996) Protein Methods, Second Edition. Wiley-Liss, New York, NY.
|
| |